www.startribune.com

www.startribune.com
Share

www.startribune.com

 •  September 22

A drug discount program that helps safety net providers save millions could be significantly weakened under new regulations proposed by the Trump Administration. Apart from looking at higher drug costs, hospitals and clinics say the biggest hit will come to programs and services for low-income or vulnerable patients. That's because the safety net...

www.startribune.com

 •  September 8

LITTLE ROCK, Ark. — A Little Rock attorney has again sued the Arkansas Department of Corrections, arguing the agency needs to publicly disclose labeling materials for an execution drug. Steven Shults is seeking labeling for the state's supply of midazolam, the first of three drugs used in Arkansas' lethal injection protocol, the Arkansas...

www.startribune.com

 •  July 13

The U.S. Food and Drug Administration should review the safety and effectiveness of all opioids, and consider the real-world impacts the powerful painkillers have, not only on patients, but also on families, crime and the demand for heroin. That's the conclusion of a sweeping report Thursday from the National Academies of Sciences, Engineering and...

www.startribune.com

 •  June 13

The Food and Drug Administration (FDA) is indefinitely delaying the requirement that food companies use the new nutrition facts labels on its products. The new label, finalized in May 2016 with support of then-First Lady Michelle Obama, draws greater attention to serving size, calories and added sugars in food products. Early opponents of the new...

www.startribune.com

 •  April 12

Inspectors with the U.S. Food and Drug Administration on Wednesday slapped St. Jude Medical with a warning letter accusing the medical device maker of failing to properly investigate problems with the batteries in its implantable defibrillators and the cybersecurity of its at-home monitoring equipment. The inspectors said that company officials...

www.startribune.com

 •  March 14

TRENTON, N.J. — U.S. regulators have approved a new drug as an initial treatment for postmenopausal women with a type of advanced breast cancer. The drug, called Kisqali and developed by Swiss drugmaker Novartis AG, is a pill that works to slow the spread of cancer by blocking two proteins that can stimulate growth and division of cancer...

www.startribune.com

 •  February 22

NEW YORK — The so-called abortion pill — now dispensed only in clinics, hospitals and doctors' offices — should be made available by prescription in pharmacies across the U.S., according to a group of doctors and public health experts urging an end to tough federal restrictions on the drug. The appeal to the Food and Drug Administration came in a...

www.startribune.com

 •  February 14

Medtronic on Monday announced the first human implant of the world’s smallest pacemaker, a vitamin-sized device that is implanted directly inside the heart. The Fridley-based medical technology giant said its Micra Transcatheter Pacing System is just one-tenth the size of a of a conventional pacemaker. Medtronic officials called the technology...

www.startribune.com

 •  February 14

A Chinese market for medical technology used to be on the long list of lofty goals for devicemakers like Medtronic. Now U.S. med-tech firms are seeing double-digit growth as they partner with Chinese manufacturers, purchase Chinese companies and race to educate and woo Chinese doctors and patients eager to tap the latest technology. A growing...

www.startribune.com

 •  February 14

WASHINGTON – The U.S. Food and Drug Administration on Friday announced the establishment of its first-ever patient advisory committee on medical devices. The new 11-member group will include nine voting members “knowledgeable in areas such as clinical research, primary care patient experience and health care needs of patient groups in the United...